Skip to content

Clinical trials

Heart Diseases trials in Hungary

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Diseases Country / region: Hungary Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20083
20093
20101
20111
20122
20132
20182
20191
20244
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting4
Unknown status2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
AstraZeneca2
Cardurion Pharmaceuticals, Inc.2
GlaxoSmithKline2
Abcentra1
Bayer1
Biotronik SE & Co. KG1
CSL Behring1
Celladon Corporation1
Daiichi Sankyo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Diseases23
Cardiovascular Diseases14
Heart Failure7
Coronary Artery Disease6
Acute Coronary Syndrome5
Myocardial Infarction5
Stroke5
Atherosclerosis4
Coronary Disease4
Myocardial Ischemia3

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.